World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
152
Citations
80642
World Ranking
1084
National Ranking
623

Overview

Jerry Avorn is affiliated with Brigham and Women's Hospital in the United States and specializes primarily in Medicine and Economics, Econometrics and Finance. Their research covers multiple subfields including Economics and Econometrics, Infectious Diseases, Pulmonary and Respiratory Medicine, Physiology, and Statistics and Probability.

Avorn's recent publications illustrate a focus on pharmaceutical regulation and public health, particularly in the context of the COVID-19 pandemic. Notable papers include:

  • FDA Approval and Regulation of Pharmaceuticals, 1983-2018 (2020) published in JAMA
  • Drug Evaluation during the Covid-19 Pandemic (2020) published in New England Journal of Medicine
  • FDA Regulation and Approval of Medical Devices: 1976-2020 (2021) published in JAMA
  • US public investment in development of mRNA covid-19 vaccines: retrospective cohort study (2023) published in BMJ
  • An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19 (2020) published in Health Affairs

The research topics they engage with include Health Systems, Economic Evaluations, Quality of Life; Pharmaceutical Economics and Policy; Pharmaceutical industry and healthcare; Pharmaceutical studies and practices; SARS-CoV-2 and COVID-19 Research; Biomedical Ethics and Regulation; and Statistical Methods in Clinical Trials.

Among frequent coauthors collaborating with Avorn are Aaron S. Kesselheim, Jonathan J. Darrow, Benjamin N. Rome, William B. Feldman, and Til Stürmer. These collaborations reflect a network around shared interests in healthcare policy, pharmaceutical research, and clinical regulation.

Avorn's work is regularly published in venues such as UNC Libraries, JAMA Network Open, New England Journal of Medicine, JAMA, and JAMA Internal Medicine. These journals reflect a broad engagement with medical research, policy, and clinical practice audiences.

Best Publications

  • Variable Selection for Propensity Score Models

    M. Alan Brookhart;Sebastian Schneeweiss;Kenneth J. Rothman;Kenneth J. Rothman;Robert J. Glynn

  • Long-term persistence in use of statin therapy in elderly patients☆

    J.S. Benner;R.J. Glynn;H. Mogun;P.J. Neumann

  • A review of uses of health care utilization databases for epidemiologic research on therapeutics

    Sebastian Schneeweiss;Jerry Avorn

  • Principles of educational outreach ('academic detailing') to improve clinical decision making.

    Stephen Bertram Soumerai;Jerry Lewis Avorn

  • Improving Drug-Therapy Decisions through Educational Outreach

    Jerry Lewis Avorn;Stephen Bertram Soumerai

  • Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications

    Philip S. Wang;Sebastian Schneeweiss;Jerry Avorn;Michael A. Fischer

  • High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

    Sebastian Schneeweiss;Jeremy A. Rassen;Robert J. Glynn;Jerry Avorn

  • Self-management education programs in chronic disease: a systematic review and methodological critique of the literature.

    Asra Warsi;Philip S. Wang;Michael P. LaValley;Jerry Avorn

  • A combined comorbidity score predicted mortality in elderly patients better than existing scores

    Joshua J. Gagne;Robert J. Glynn;Jerry Avorn;Raisa Levin

  • Scientific versus commercial sources of influence on the prescribing behavior of physicians

    Jerry Avorn;Milton Chen;Robert Hartley

  • Reduction of bacteriuria and pyuria after ingestion of cranberry juice.

    Jerry Avorn;Mark Monane;Jerry H. Gurwitz;Robert J. Glynn

  • Incidence and preventability of adverse drug events in nursing homes.

    Jerry H. Gurwitz;Terry S. Field;Jerry Avorn;Jerry Avorn;Danny McCormick

  • Persistence of Use of Lipid-Lowering Medications: A Cross-National Study

    Jerry Avorn;Johanne Monette;Anne Lacour;Rhonda L. Bohn

  • Performance of Comorbidity Scores to Control for Confounding in Epidemiologic Studies using Claims Data

    Sebastian Schneeweiss;John D. Seeger;Malcolm Maclure;Philip S. Wang

  • Adherence to Therapy With Oral Antineoplastic Agents

    Ann H. Partridge;Jerry Avorn;Philip S. Wang;Eric P. Winer

  • Full coverage for preventive medications after myocardial infarction

    Niteesh K. Choudhry;Jerry Avorn;Robert J. Glynn;Elliott M. Antman

  • Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer

    Ann H. Partridge;Philip S. Wang;Eric P. Winer;Jerry Avorn

  • The exclusion of the elderly and women from clinical trials in acute myocardial infarction.

    Jerry H. Gurwitz;Nananda F. Col;Jerry Avorn

  • Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes.

    Stephen Bertram Soumerai;Dennis Ross-Degnan;Jerry Lewis Avorn;Thomas J. McLaughlin

  • A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

    Til Stürmer;Manisha Joshi;Robert J. Glynn;Jerry Avorn

Frequent Co-Authors

Robert J. Glynn
Robert J. Glynn Harvard Medical School
Sebastian Schneeweiss
Sebastian Schneeweiss Brigham and Women's Hospital
Daniel H. Solomon
Daniel H. Solomon Brigham and Women's Hospital
Jerry H. Gurwitz
Jerry H. Gurwitz University of Massachusetts Chan Medical School
Niteesh K. Choudhry
Niteesh K. Choudhry Brigham and Women's Hospital
William H. Shrank
William H. Shrank Humana (United States)
Philip S. Wang
Philip S. Wang Harvard Medical School
Kenneth J. Rothman
Kenneth J. Rothman Boston University
Stephen B. Soumerai
Stephen B. Soumerai Harvard University
M. Alan Brookhart
M. Alan Brookhart University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA doesn’t just mean medical school. Many healthcare professionals begin with practical, online degree options that are flexible and career-oriented. For registered nurses looking to advance their credentials, an online rn to bsn no clinicals program offers an accessible way to earn a bachelor’s degree without the need for traditional in-person clinicals.

Those interested in fast-tracking their careers might consider a 6 month lpn program online, providing a rapid pathway to becoming a licensed practical nurse. For nurses aiming for the highest level of clinical practice, several options are available. The fastest dnp online program allows for completion in a reduced timeframe, while the easiest dnp program online helps identify the most flexible and manageable Doctor of Nursing Practice programs available.

By exploring these alternative and accelerated educational pathways, students and professionals can advance their healthcare careers while balancing work and life commitments.

Best Scientists Citing Jerry Avorn

Trending Scientists

Recently Published Articles